Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the In Vitro Diagnostics (IVD) companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional In Vitro Diagnostics (IVD) market. Further, it explains the major drivers and regional dynamics of the global In Vitro Diagnostics (IVD) market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Pfizer
Thermo Fisher Scientific
Abbott
Biomerieux
Danaher Corporation
F. Hoffmann-La Roche
Becton Dickinson and Company
Bio-Rad Laboratories
Bayer AG
Sysmex Corporation
Johnson & Johnson
Hologic Inc
NEC Corp
Simens Healthcare
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
In Vitro Diagnostics (IVD) Segment by Type
Reagents
Instruments
Software and Services
In Vitro Diagnostics (IVD) Segment by Application
Standalone Laboratory
Hospitals
Academic and Medical Schools
Point of Care Testing
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the In Vitro Diagnostics (IVD) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for In Vitro Diagnostics (IVD) market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of In Vitro Diagnostics (IVD), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for In Vitro Diagnostics (IVD), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the In Vitro Diagnostics (IVD) revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global In Vitro Diagnostics (IVD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for In Vitro Diagnostics (IVD) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Thermo Fisher Scientific, Abbott, Biomerieux, Danaher Corporation, F. Hoffmann-La Roche, Becton Dickinson and Company, Bio-Rad Laboratories and Bayer AG, etc.
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the In Vitro Diagnostics (IVD) companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional In Vitro Diagnostics (IVD) market. Further, it explains the major drivers and regional dynamics of the global In Vitro Diagnostics (IVD) market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Pfizer
Thermo Fisher Scientific
Abbott
Biomerieux
Danaher Corporation
F. Hoffmann-La Roche
Becton Dickinson and Company
Bio-Rad Laboratories
Bayer AG
Sysmex Corporation
Johnson & Johnson
Hologic Inc
NEC Corp
Simens Healthcare
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
In Vitro Diagnostics (IVD) Segment by Type
Reagents
Instruments
Software and Services
In Vitro Diagnostics (IVD) Segment by Application
Standalone Laboratory
Hospitals
Academic and Medical Schools
Point of Care Testing
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the In Vitro Diagnostics (IVD) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for In Vitro Diagnostics (IVD) market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of In Vitro Diagnostics (IVD), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for In Vitro Diagnostics (IVD), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the In Vitro Diagnostics (IVD) revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global In Vitro Diagnostics (IVD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for In Vitro Diagnostics (IVD) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Thermo Fisher Scientific, Abbott, Biomerieux, Danaher Corporation, F. Hoffmann-La Roche, Becton Dickinson and Company, Bio-Rad Laboratories and Bayer AG, etc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Diagnostics (IVD) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Reagents
1.2.3 Instruments
1.2.4 Software and Services
1.3 Market by Application
1.3.1 Global In Vitro Diagnostics (IVD) Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Standalone Laboratory
1.3.3 Hospitals
1.3.4 Academic and Medical Schools
1.3.5 Point of Care Testing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global In Vitro Diagnostics (IVD) Market Size (2017-2028)
2.2 In Vitro Diagnostics (IVD) Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global In Vitro Diagnostics (IVD) Market Size by Region (2017-2022)
2.4 Global In Vitro Diagnostics (IVD) Market Size Forecast by Region (2023-2028)
2.5 Global Top In Vitro Diagnostics (IVD) Countries Ranking by Market Size
3 In Vitro Diagnostics (IVD) Competitive by Company
3.1 Global In Vitro Diagnostics (IVD) Revenue by Players
3.1.1 Global In Vitro Diagnostics (IVD) Revenue by Players (2017-2022)
3.1.2 Global In Vitro Diagnostics (IVD) Market Share by Players (2017-2022)
3.2 Global In Vitro Diagnostics (IVD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by In Vitro Diagnostics (IVD) Revenue
3.4 Global In Vitro Diagnostics (IVD) Market Concentration Ratio
3.4.1 Global In Vitro Diagnostics (IVD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostics (IVD) Revenue in 2021
3.5 Global In Vitro Diagnostics (IVD) Key Players Head office and Area Served
3.6 Key Players In Vitro Diagnostics (IVD) Product Solution and Service
3.7 Date of Enter into In Vitro Diagnostics (IVD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global In Vitro Diagnostics (IVD) Breakdown Data by Type
4.1 Global In Vitro Diagnostics (IVD) Historic Revenue by Type (2017-2022)
4.2 Global In Vitro Diagnostics (IVD) Forecasted Revenue by Type (2023-2028)
5 Global In Vitro Diagnostics (IVD) Breakdown Data by Application
5.1 Global In Vitro Diagnostics (IVD) Historic Market Size by Application (2017-2022)
5.2 Global In Vitro Diagnostics (IVD) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America In Vitro Diagnostics (IVD) Revenue by Company (2020-2022)
6.2 North America In Vitro Diagnostics (IVD) Revenue by Type (2017-2028)
6.3 North America In Vitro Diagnostics (IVD) Revenue by Application (2017-2028)
6.4 North America In Vitro Diagnostics (IVD) Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe In Vitro Diagnostics (IVD) Revenue by Company (2020-2022)
7.2 Europe In Vitro Diagnostics (IVD) Revenue by Type (2017-2028)
7.3 Europe In Vitro Diagnostics (IVD) Revenue by Application (2017-2028)
7.4 Europe In Vitro Diagnostics (IVD) Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific In Vitro Diagnostics (IVD) Revenue by Company (2020-2022)
8.2 Asia Pacific In Vitro Diagnostics (IVD) Revenue by Type (2017-2028)
8.3 Asia Pacific In Vitro Diagnostics (IVD) Revenue by Application (2017-2028)
8.4 Asia Pacific In Vitro Diagnostics (IVD) Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America In Vitro Diagnostics (IVD) Revenue by Company (2020-2022)
9.2 Latin America In Vitro Diagnostics (IVD) Revenue by Type (2017-2028)
9.3 Latin America In Vitro Diagnostics (IVD) Revenue by Application (2017-2028)
9.4 Latin America In Vitro Diagnostics (IVD) Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa In Vitro Diagnostics (IVD) Revenue by Company (2020-2022)
10.2 Middle East and Africa In Vitro Diagnostics (IVD) Revenue by Type (2017-2028)
10.3 Middle East and Africa In Vitro Diagnostics (IVD) Revenue by Application (2017-2028)
10.4 Middle East and Africa In Vitro Diagnostics (IVD) Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer In Vitro Diagnostics (IVD) Products and Services
11.1.4 Pfizer In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.1.5 Pfizer In Vitro Diagnostics (IVD) SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Products and Services
11.2.4 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.2.5 Thermo Fisher Scientific In Vitro Diagnostics (IVD) SWOT Analysis
11.2.6 Thermo Fisher Scientific Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott In Vitro Diagnostics (IVD) Products and Services
11.3.4 Abbott In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.3.5 Abbott In Vitro Diagnostics (IVD) SWOT Analysis
11.3.6 Abbott Recent Developments
11.4 Biomerieux
11.4.1 Biomerieux Company Details
11.4.2 Biomerieux Business Overview
11.4.3 Biomerieux In Vitro Diagnostics (IVD) Products and Services
11.4.4 Biomerieux In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.4.5 Biomerieux In Vitro Diagnostics (IVD) SWOT Analysis
11.4.6 Biomerieux Recent Developments
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation In Vitro Diagnostics (IVD) Products and Services
11.5.4 Danaher Corporation In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.5.5 Danaher Corporation In Vitro Diagnostics (IVD) SWOT Analysis
11.5.6 Danaher Corporation Recent Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Details
11.6.2 F. Hoffmann-La Roche Business Overview
11.6.3 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Products and Services
11.6.4 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.6.5 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) SWOT Analysis
11.6.6 F. Hoffmann-La Roche Recent Developments
11.7 Becton Dickinson and Company
11.7.1 Becton Dickinson and Company Company Details
11.7.2 Becton Dickinson and Company Business Overview
11.7.3 Becton Dickinson and Company In Vitro Diagnostics (IVD) Products and Services
11.7.4 Becton Dickinson and Company In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.7.5 Becton Dickinson and Company In Vitro Diagnostics (IVD) SWOT Analysis
11.7.6 Becton Dickinson and Company Recent Developments
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Products and Services
11.8.4 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.8.5 Bio-Rad Laboratories In Vitro Diagnostics (IVD) SWOT Analysis
11.8.6 Bio-Rad Laboratories Recent Developments
11.9 Bayer AG
11.9.1 Bayer AG Company Details
11.9.2 Bayer AG Business Overview
11.9.3 Bayer AG In Vitro Diagnostics (IVD) Products and Services
11.9.4 Bayer AG In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.9.5 Bayer AG In Vitro Diagnostics (IVD) SWOT Analysis
11.9.6 Bayer AG Recent Developments
11.10 Sysmex Corporation
11.10.1 Sysmex Corporation Company Details
11.10.2 Sysmex Corporation Business Overview
11.10.3 Sysmex Corporation In Vitro Diagnostics (IVD) Products and Services
11.10.4 Sysmex Corporation In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.10.5 Sysmex Corporation In Vitro Diagnostics (IVD) SWOT Analysis
11.10.6 Sysmex Corporation Recent Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Details
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson In Vitro Diagnostics (IVD) Products and Services
11.11.4 Johnson & Johnson In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.11.5 Johnson & Johnson Recent Developments
11.12 Hologic Inc
11.12.1 Hologic Inc Company Details
11.12.2 Hologic Inc Business Overview
11.12.3 Hologic Inc In Vitro Diagnostics (IVD) Products and Services
11.12.4 Hologic Inc In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.12.5 Hologic Inc Recent Developments
11.13 NEC Corp
11.13.1 NEC Corp Company Details
11.13.2 NEC Corp Business Overview
11.13.3 NEC Corp In Vitro Diagnostics (IVD) Products and Services
11.13.4 NEC Corp In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.13.5 NEC Corp Recent Developments
11.14 Simens Healthcare
11.14.1 Simens Healthcare Company Details
11.14.2 Simens Healthcare Business Overview
11.14.3 Simens Healthcare In Vitro Diagnostics (IVD) Products and Services
11.14.4 Simens Healthcare In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.14.5 Simens Healthcare Recent Developments
12 In Vitro Diagnostics (IVD) Market Dynamics
12.1 In Vitro Diagnostics (IVD) Market Trends
12.2 In Vitro Diagnostics (IVD) Market Drivers
12.3 In Vitro Diagnostics (IVD) Market Challenges
12.4 In Vitro Diagnostics (IVD) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Diagnostics (IVD) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Reagents
1.2.3 Instruments
1.2.4 Software and Services
1.3 Market by Application
1.3.1 Global In Vitro Diagnostics (IVD) Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Standalone Laboratory
1.3.3 Hospitals
1.3.4 Academic and Medical Schools
1.3.5 Point of Care Testing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global In Vitro Diagnostics (IVD) Market Size (2017-2028)
2.2 In Vitro Diagnostics (IVD) Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global In Vitro Diagnostics (IVD) Market Size by Region (2017-2022)
2.4 Global In Vitro Diagnostics (IVD) Market Size Forecast by Region (2023-2028)
2.5 Global Top In Vitro Diagnostics (IVD) Countries Ranking by Market Size
3 In Vitro Diagnostics (IVD) Competitive by Company
3.1 Global In Vitro Diagnostics (IVD) Revenue by Players
3.1.1 Global In Vitro Diagnostics (IVD) Revenue by Players (2017-2022)
3.1.2 Global In Vitro Diagnostics (IVD) Market Share by Players (2017-2022)
3.2 Global In Vitro Diagnostics (IVD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by In Vitro Diagnostics (IVD) Revenue
3.4 Global In Vitro Diagnostics (IVD) Market Concentration Ratio
3.4.1 Global In Vitro Diagnostics (IVD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostics (IVD) Revenue in 2021
3.5 Global In Vitro Diagnostics (IVD) Key Players Head office and Area Served
3.6 Key Players In Vitro Diagnostics (IVD) Product Solution and Service
3.7 Date of Enter into In Vitro Diagnostics (IVD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global In Vitro Diagnostics (IVD) Breakdown Data by Type
4.1 Global In Vitro Diagnostics (IVD) Historic Revenue by Type (2017-2022)
4.2 Global In Vitro Diagnostics (IVD) Forecasted Revenue by Type (2023-2028)
5 Global In Vitro Diagnostics (IVD) Breakdown Data by Application
5.1 Global In Vitro Diagnostics (IVD) Historic Market Size by Application (2017-2022)
5.2 Global In Vitro Diagnostics (IVD) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America In Vitro Diagnostics (IVD) Revenue by Company (2020-2022)
6.2 North America In Vitro Diagnostics (IVD) Revenue by Type (2017-2028)
6.3 North America In Vitro Diagnostics (IVD) Revenue by Application (2017-2028)
6.4 North America In Vitro Diagnostics (IVD) Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe In Vitro Diagnostics (IVD) Revenue by Company (2020-2022)
7.2 Europe In Vitro Diagnostics (IVD) Revenue by Type (2017-2028)
7.3 Europe In Vitro Diagnostics (IVD) Revenue by Application (2017-2028)
7.4 Europe In Vitro Diagnostics (IVD) Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific In Vitro Diagnostics (IVD) Revenue by Company (2020-2022)
8.2 Asia Pacific In Vitro Diagnostics (IVD) Revenue by Type (2017-2028)
8.3 Asia Pacific In Vitro Diagnostics (IVD) Revenue by Application (2017-2028)
8.4 Asia Pacific In Vitro Diagnostics (IVD) Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America In Vitro Diagnostics (IVD) Revenue by Company (2020-2022)
9.2 Latin America In Vitro Diagnostics (IVD) Revenue by Type (2017-2028)
9.3 Latin America In Vitro Diagnostics (IVD) Revenue by Application (2017-2028)
9.4 Latin America In Vitro Diagnostics (IVD) Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa In Vitro Diagnostics (IVD) Revenue by Company (2020-2022)
10.2 Middle East and Africa In Vitro Diagnostics (IVD) Revenue by Type (2017-2028)
10.3 Middle East and Africa In Vitro Diagnostics (IVD) Revenue by Application (2017-2028)
10.4 Middle East and Africa In Vitro Diagnostics (IVD) Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer In Vitro Diagnostics (IVD) Products and Services
11.1.4 Pfizer In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.1.5 Pfizer In Vitro Diagnostics (IVD) SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Products and Services
11.2.4 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.2.5 Thermo Fisher Scientific In Vitro Diagnostics (IVD) SWOT Analysis
11.2.6 Thermo Fisher Scientific Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott In Vitro Diagnostics (IVD) Products and Services
11.3.4 Abbott In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.3.5 Abbott In Vitro Diagnostics (IVD) SWOT Analysis
11.3.6 Abbott Recent Developments
11.4 Biomerieux
11.4.1 Biomerieux Company Details
11.4.2 Biomerieux Business Overview
11.4.3 Biomerieux In Vitro Diagnostics (IVD) Products and Services
11.4.4 Biomerieux In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.4.5 Biomerieux In Vitro Diagnostics (IVD) SWOT Analysis
11.4.6 Biomerieux Recent Developments
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation In Vitro Diagnostics (IVD) Products and Services
11.5.4 Danaher Corporation In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.5.5 Danaher Corporation In Vitro Diagnostics (IVD) SWOT Analysis
11.5.6 Danaher Corporation Recent Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Details
11.6.2 F. Hoffmann-La Roche Business Overview
11.6.3 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Products and Services
11.6.4 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.6.5 F. Hoffmann-La Roche In Vitro Diagnostics (IVD) SWOT Analysis
11.6.6 F. Hoffmann-La Roche Recent Developments
11.7 Becton Dickinson and Company
11.7.1 Becton Dickinson and Company Company Details
11.7.2 Becton Dickinson and Company Business Overview
11.7.3 Becton Dickinson and Company In Vitro Diagnostics (IVD) Products and Services
11.7.4 Becton Dickinson and Company In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.7.5 Becton Dickinson and Company In Vitro Diagnostics (IVD) SWOT Analysis
11.7.6 Becton Dickinson and Company Recent Developments
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Products and Services
11.8.4 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.8.5 Bio-Rad Laboratories In Vitro Diagnostics (IVD) SWOT Analysis
11.8.6 Bio-Rad Laboratories Recent Developments
11.9 Bayer AG
11.9.1 Bayer AG Company Details
11.9.2 Bayer AG Business Overview
11.9.3 Bayer AG In Vitro Diagnostics (IVD) Products and Services
11.9.4 Bayer AG In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.9.5 Bayer AG In Vitro Diagnostics (IVD) SWOT Analysis
11.9.6 Bayer AG Recent Developments
11.10 Sysmex Corporation
11.10.1 Sysmex Corporation Company Details
11.10.2 Sysmex Corporation Business Overview
11.10.3 Sysmex Corporation In Vitro Diagnostics (IVD) Products and Services
11.10.4 Sysmex Corporation In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.10.5 Sysmex Corporation In Vitro Diagnostics (IVD) SWOT Analysis
11.10.6 Sysmex Corporation Recent Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Details
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson In Vitro Diagnostics (IVD) Products and Services
11.11.4 Johnson & Johnson In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.11.5 Johnson & Johnson Recent Developments
11.12 Hologic Inc
11.12.1 Hologic Inc Company Details
11.12.2 Hologic Inc Business Overview
11.12.3 Hologic Inc In Vitro Diagnostics (IVD) Products and Services
11.12.4 Hologic Inc In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.12.5 Hologic Inc Recent Developments
11.13 NEC Corp
11.13.1 NEC Corp Company Details
11.13.2 NEC Corp Business Overview
11.13.3 NEC Corp In Vitro Diagnostics (IVD) Products and Services
11.13.4 NEC Corp In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.13.5 NEC Corp Recent Developments
11.14 Simens Healthcare
11.14.1 Simens Healthcare Company Details
11.14.2 Simens Healthcare Business Overview
11.14.3 Simens Healthcare In Vitro Diagnostics (IVD) Products and Services
11.14.4 Simens Healthcare In Vitro Diagnostics (IVD) Revenue in In Vitro Diagnostics (IVD) Business (2017-2022)
11.14.5 Simens Healthcare Recent Developments
12 In Vitro Diagnostics (IVD) Market Dynamics
12.1 In Vitro Diagnostics (IVD) Market Trends
12.2 In Vitro Diagnostics (IVD) Market Drivers
12.3 In Vitro Diagnostics (IVD) Market Challenges
12.4 In Vitro Diagnostics (IVD) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.